Ovidius specialises in bringing innovation to the UK from around the world in spine, orthopaedics, and neurosurgery. Putting customer service at the forefront of our business, as well as offering the highest quality products, makes us an educated choice for your practice.
Founded in 2016, Ovidius Medical is a privately owned medical technology company specialising in innovative solutions for complex musculoskeletal pathologies, with particular expertise in spinal and orthopaedic oncology.
In March 2026, we celebrated our 10-year anniversary. Over that decade, we have built our reputation on clinical expertise, exceptional service and, above all, reliability. We are particularly proud that throughout those 10 years, we have never failed to deliver the technology required for a patient’s planned surgery.
Our team has developed extensive experience supporting complex oncology procedures across the UK, working closely with surgeons and multidisciplinary teams where careful planning, responsiveness and dependable support are critical. We understand that the technology we provide forms only one part of a much wider patient pathway, and our approach is always centred around helping clinical teams achieve the best possible outcome for each individual patient.
Alongside our specialist oncology experience, we continue to introduce novel technologies that improve surgical planning, workflow and patient care across spine and orthopaedics. We work collaboratively with clinicians and manufacturing partners to ensure the technologies we represent are supported by appropriate clinical evidence, education and practical expertise.
With more than 30 years of combined life sciences experience within our leadership team, Ovidius Medical remains committed to advancing research, education and treatment while maintaining the responsive, personal service on which our reputation has been built.
UPHOLDING THE HIGHEST STANDARDS IN EVERYTHING WE DO.
ADVANCING CLINICAL WORKFLOWS WITH INNOVATIVE TECHNOLOGY.
SUPPORTING CLINICIANS TO IMPLEMENT BREAKTHROUGH TECHNOLOGIES.